www.fdanews.com/articles/120832-biocryst-initiates-phase-ii-study-of-gout-drug

BioCryst Initiates Phase II Study of Gout Drug

September 28, 2009

BioCryst Pharmaceuticals, Inc. announced that it is initiating a Phase II study of BCX4208 for the treatment of gout.
TradingMarkets